FDMT PEER ANALYSIS

4D Molecular Therapeutics Inc — metric-by-metric comparison with peers and the industry median

FDMT4D Molecular Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

FDMTIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	FDMT	MSB	TLX	RTALB	CSL	Ind. Median
P/E	—	—	—	4.78●	29.96	18.06
P/B	1.93	—	6.38	0.59●	2.24	3.62
EV/EBITDA	—	—	120.20	72.98	10.35●	15.13
P/S	9.89	31.30	3.24	6.52	2.66●	10.65

Financial Health
Metric	FDMT	MSB	TLX	RTALB	CSL	Ind. Median
Current Ratio	9.34●	—	1.43	1.21	2.57	5.90
Debt/Equity	4.5%	—	112.3%	1.2%●	67.4%	10.9%
NetDebt/EBITDA	2.27	—	13.13	0.90●	2.22	1.15

Profitability
Metric	FDMT	MSB	TLX	RTALB	CSL	Ind. Median
Net Margin	-182.3%	-115.3%	-0.9%	136.3%●	9.2%	-125.7%
ROE	-34.9%	-11.3%	-1.8%	15.1%●	7.7%	-47.5%
ROA	-31.3%	-8.6%	-0.7%	13.1%●	3.8%	-35.8%
EBITDA Margin	-185.2%	-76.6%	3.0%	9.0%	32.8%●	-105.8%

Growth + Dividend
Metric	FDMT	MSB	TLX	RTALB	CSL	Ind. Median
Rev. Growth	383,560.9%●	410.4%	56.3%	24.0%	4.8%	5.1%
NI Growth	—	—	—	134.0%●	-39.4%	12.1%
Div. Yield	—	0.0%	—	0.0%	2.5%●	0.2%
Payout	—	0.0%	—	0.0%	103.1%	0.0%

Valuation
Metric	FDMT	MRVI	TBPH	GERN	PHAT	SPRY	Ind. Median
P/E	—	—	7.62	—	—	—	18.06
P/B	1.93	4.10	3.00	4.35	-2.81●	13.26	3.62
EV/EBITDA	—	—	3.87	—	—	—	15.13
P/S	9.89	4.23●	7.95	5.09	4.63	8.22	10.65

Financial Health
Metric	FDMT	MRVI	TBPH	GERN	PHAT	SPRY	Ind. Median
Current Ratio	9.34	5.91	13.14●	6.78	2.21	4.94	5.90
Debt/Equity	4.5%	128.0%	25.2%	109.9%	-49.4%●	157.4%	10.9%
NetDebt/EBITDA	2.27	-1.01	-2.26●	1.69	0.16	0.54	1.15

Profitability
Metric	FDMT	MRVI	TBPH	GERN	PHAT	SPRY	Ind. Median
Net Margin	-182.3%	-51.1%	104.3%●	-35.5%	-76.8%	-200.0%	-125.7%
ROE	-34.9%	-40.8%	50.2%●	-28.0%	—	-136.4%	-47.5%
ROA	-31.3%	-12.5%	28.1%●	-12.7%	-52.5%	-64.4%	-35.8%
EBITDA Margin	-185.2%	-50.8%	129.8%●	-18.8%	-44.4%	-194.1%	-105.8%

Growth + Dividend
Metric	FDMT	MRVI	TBPH	GERN	PHAT	SPRY	Ind. Median
Rev. Growth	383,560.9%●	-15.4%	68.2%	68.6%	150.3%	1.9%	5.1%
NI Growth	—	—	—	—	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on FDMT

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.